CARGO Therapeutics (CRGX) News Today $11.94 -1.56 (-11.56%) As of 02:57 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period CARGO Therapeutics (NASDAQ:CRGX) Hits New 1-Year Low - What's Next?CARGO Therapeutics (NASDAQ:CRGX) Reaches New 1-Year Low - What's Next?January 13 at 10:43 AM | marketbeat.comJane Street Group LLC Decreases Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX)Jane Street Group LLC decreased its stake in shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 73.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,707 shares of the company's stock after selling 44,299 shares during the period.January 11 at 3:16 AM | marketbeat.comCARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025January 10 at 8:10 AM | finance.yahoo.comCARGO Therapeutics (NASDAQ:CRGX) Shares Up 7.4% - Still a Buy?CARGO Therapeutics (NASDAQ:CRGX) Trading 7.4% Higher - Here's What HappenedJanuary 7, 2025 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Shares Down 4.8% - Should You Sell?CARGO Therapeutics (NASDAQ:CRGX) Stock Price Down 4.8% - What's Next?January 6, 2025 | marketbeat.comCARGO Therapeutics, Inc. (NASDAQ:CRGX) Sees Significant Growth in Short InterestCARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 6,050,000 shares, a growth of 7.1% from the November 30th total of 5,650,000 shares. Currently, 18.9% of the company's shares are sold short. Based on an average trading volume of 222,000 shares, the days-to-cover ratio is currently 27.3 days.January 2, 2025 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Trading 5.7% Higher - Here's WhyCARGO Therapeutics (NASDAQ:CRGX) Stock Price Up 5.7% - Should You Buy?December 31, 2024 | marketbeat.comCargo Therapeutics (NASDAQ:CRGX) Stock Quotes, Forecast and News SummaryDecember 31, 2024 | benzinga.comBarclays PLC Purchases 39,102 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX)Barclays PLC lifted its position in CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 226.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 56,354 shares of the company's stock after acquiring an additional 39,102 shares during theDecember 31, 2024 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Trading Down 6.2% - What's Next?CARGO Therapeutics (NASDAQ:CRGX) Stock Price Down 6.2% - Should You Sell?December 30, 2024 | marketbeat.comGeode Capital Management LLC Has $15.47 Million Stock Holdings in CARGO Therapeutics, Inc. (NASDAQ:CRGX)Geode Capital Management LLC grew its holdings in shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 80.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 838,279 shares of the company's stock afterDecember 30, 2024 | marketbeat.comCARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Consensus Recommendation of "Buy" by BrokeragesCARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) has been given an average rating of "Buy" by the six research firms that are presently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month target pricDecember 30, 2024 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Shares Gap Down - Should You Sell?CARGO Therapeutics (NASDAQ:CRGX) Shares Gap Down - Time to Sell?December 26, 2024 | marketbeat.comState Street Corp Acquires 88,000 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX)State Street Corp increased its holdings in shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 11.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 839,861 shares of the company's stoDecember 25, 2024 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Trading Down 3.7% - Should You Sell?CARGO Therapeutics (NASDAQ:CRGX) Stock Price Down 3.7% - Here's What HappenedDecember 24, 2024 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Stock Price Up 5.4% - Here's WhyCARGO Therapeutics (NASDAQ:CRGX) Trading Up 5.4% - Should You Buy?December 20, 2024 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Reaches New 1-Year Low - Here's What HappenedCARGO Therapeutics (NASDAQ:CRGX) Reaches New 52-Week Low - Here's What HappenedDecember 19, 2024 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Trading Down 5.1% - Time to Sell?CARGO Therapeutics (NASDAQ:CRGX) Shares Down 5.1% - Here's What HappenedDecember 18, 2024 | marketbeat.comCARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | globenewswire.comCARGO Therapeutics (NASDAQ:CRGX) Sets New 12-Month Low - Here's WhyCARGO Therapeutics (NASDAQ:CRGX) Sets New 52-Week Low - Time to Sell?December 13, 2024 | marketbeat.comWellington Management Group LLP Has $37.69 Million Stock Holdings in CARGO Therapeutics, Inc. (NASDAQ:CRGX)Wellington Management Group LLP lifted its stake in shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 4.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,042,723 shares of the company's stock aftDecember 13, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Has $5.46 Million Stock Holdings in CARGO Therapeutics, Inc. (NASDAQ:CRGX)Charles Schwab Investment Management Inc. increased its stake in shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 87.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 29December 13, 2024 | marketbeat.comCARGO Therapeutics, Inc. (CRGX) Receives a Buy from Truist FinancialDecember 10, 2024 | markets.businessinsider.comCARGO Therapeutics, Inc.: Buy Rating Backed by Promising CAR-T Developments and Positive Clinical DataDecember 9, 2024 | markets.businessinsider.comCARGO Therapeutics (NASDAQ:CRGX) Trading Up 8.7% - What's Next?CARGO Therapeutics (NASDAQ:CRGX) Shares Up 8.7% - Here's WhyDecember 6, 2024 | marketbeat.comJanus Henderson Group PLC Has $49.34 Million Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX)Janus Henderson Group PLC raised its holdings in CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 1.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,675,285 shares of the company's stock after aDecember 6, 2024 | marketbeat.comCARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Average Recommendation of "Buy" by BrokeragesCARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) has been assigned an average rating of "Buy" from the six research firms that are covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokers thatDecember 5, 2024 | marketbeat.comCARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Purchased by Fmr LLCFmr LLC increased its holdings in CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) by 1.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 6,954,476 shares of the company's stock after acquiring an additional 77,508 shares during the period. Fmr LLC owneDecember 4, 2024 | marketbeat.comSio Capital Management LLC Takes Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX)Sio Capital Management LLC bought a new position in CARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 173,860 shares of the company's stock, valued at appNovember 29, 2024 | marketbeat.comEquities Analysts Offer Predictions for CRGX FY2024 EarningsCARGO Therapeutics, Inc. (NASDAQ:CRGX - Free Report) - William Blair issued their FY2024 earnings per share (EPS) estimates for shares of CARGO Therapeutics in a report released on Tuesday, November 26th. William Blair analyst S. Corwin anticipates that the company will post earnings of ($3.74) pNovember 28, 2024 | marketbeat.comCargo Therapeutics draws bullish view at William Blair on lead assetNovember 26, 2024 | seekingalpha.comWilliam Blair Initiates Coverage of CARGO Therapeutics (CRGX) with Outperform RecommendationNovember 26, 2024 | msn.comPromising Advancements in CAR-T Cell Therapies: CARGO Therapeutics’ Potential with Firi-cel and CRG-023November 26, 2024 | markets.businessinsider.comCARGO Therapeutics (NASDAQ:CRGX) Earns Outperform Rating from Analysts at William BlairWilliam Blair started coverage on CARGO Therapeutics in a research note on Tuesday. They issued an "outperform" rating on the stock.November 26, 2024 | marketbeat.comPromising Outlook for Cargo Therapeutics: Buy Rating Backed by Strong Financials and Clinical DevelopmentsNovember 15, 2024 | markets.businessinsider.comCARGO Therapeutics' (CRGX) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and issued a $33.00 target price on shares of CARGO Therapeutics in a research report on Friday.November 15, 2024 | marketbeat.comPromising Developments and Financial Stability Drive Buy Rating for CARGO TherapeuticsNovember 14, 2024 | markets.businessinsider.comCARGO Therapeutics, Inc. (CRGX) Gets a Buy from Piper SandlerNovember 14, 2024 | markets.businessinsider.comCARGO Therapeutics Advances in Cancer Therapy DevelopmentNovember 14, 2024 | tipranks.comCARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 13, 2024 | markets.businessinsider.comCARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Average Rating of "Buy" from AnalystsCARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) has been assigned a consensus rating of "Buy" from the seven analysts that are covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1-year target price among brokeraNovember 10, 2024 | marketbeat.comCargo Therapeutics announces ASH 2024 abstract on CRG-023November 6, 2024 | markets.businessinsider.comCARGO Therapeutics to Participate in Upcoming Investor ConferencesNovember 5, 2024 | globenewswire.comCARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma ActivityNovember 5, 2024 | globenewswire.comCARGO Therapeutics, Inc. (NASDAQ:CRGX) Short Interest UpdateCARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 5,430,000 shares, a growth of 7.1% from the September 30th total of 5,070,000 shares. Approximately 17.2% of the shares of the stock are sold short. Based on an average trading volume of 317,000 shares, the days-to-cover ratio is presently 17.1 days.November 1, 2024 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Trading Down 5.9% - Here's WhyCARGO Therapeutics (NASDAQ:CRGX) Stock Price Down 5.9% - Here's WhyOctober 21, 2024 | marketbeat.comHere's Why We're Not Too Worried About CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn SituationOctober 18, 2024 | finance.yahoo.comCARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Average Rating of "Buy" by AnalystsCARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) has been assigned an average recommendation of "Buy" from the seven research firms that are currently covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 12 month price objOctober 16, 2024 | marketbeat.comShort Interest in CARGO Therapeutics, Inc. (NASDAQ:CRGX) Rises By 21.6%CARGO Therapeutics, Inc. (NASDAQ:CRGX - Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 5,070,000 shares, an increase of 21.6% from the September 15th total of 4,170,000 shares. Approximately 16.1% of the shares of the stock are sold short. Based on an average trading volume of 325,200 shares, the short-interest ratio is presently 15.6 days.October 14, 2024 | marketbeat.comCARGO Therapeutics (NASDAQ:CRGX) Trading Up 6.2% - Time to Buy?CARGO Therapeutics (NASDAQ:CRGX) Trading 6.2% Higher - Here's What HappenedOctober 11, 2024 | marketbeat.com Get CARGO Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter. Email Address CRGX Media Mentions By Week CRGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRGX News Sentiment▼1.250.95▲Average Medical News Sentiment CRGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRGX Articles This Week▼72▲CRGX Articles Average Week Get CARGO Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EWTX News Today DYN News Today ARWR News Today CPRX News Today AMRX News Today NAMS News Today LBPH News Today IOVA News Today PTGX News Today CGON News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRGX) was last updated on 1/13/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.